These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Tailoring tacrolimus-based immunotherapy in renal transplantation. Yang HC Nephrol Dial Transplant; 2003 May; 18 Suppl 1():i16-20. PubMed ID: 12738759 [TBL] [Abstract][Full Text] [Related]
5. Tacrolimus: a further update of its use in the management of organ transplantation. Scott LJ; McKeage K; Keam SJ; Plosker GL Drugs; 2003; 63(12):1247-97. PubMed ID: 12790696 [TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results. Krämer BK; Montagnino G; Del Castillo D; Margreiter R; Sperschneider H; Olbricht CJ; Krüger B; Ortuño J; Köhler H; Kunzendorf U; Stummvoll HK; Tabernero JM; Mühlbacher F; Rivero M; Arias M; Nephrol Dial Transplant; 2005 May; 20(5):968-73. PubMed ID: 15741208 [TBL] [Abstract][Full Text] [Related]
7. Tacrolimus versus cyclosporin as primary immunosuppression for kidney transplant recipients. Webster A; Woodroffe RC; Taylor RS; Chapman JR; Craig JC Cochrane Database Syst Rev; 2005 Oct; (4):CD003961. PubMed ID: 16235347 [TBL] [Abstract][Full Text] [Related]
8. Randomized trial of mycophenolate mofetil versus enteric-coated mycophenolate sodium in primary renal transplant recipients given tacrolimus and daclizumab/thymoglobulin: one year follow-up. Ciancio G; Burke GW; Gaynor JJ; Roth D; Sageshima J; Kupin W; Tueros L; Hanson L; Rosen A; Ruiz P; Miller J Transplantation; 2008 Jul; 86(1):67-74. PubMed ID: 18622280 [TBL] [Abstract][Full Text] [Related]
9. Long-term renal transplant function in recipient of simultaneous kidney and pancreas transplant maintained with two prednisone-free maintenance immunosuppressive combinations: tacrolimus/mycophenolate mofetil versus tacrolimus/sirolimus. Gallon LG; Winoto J; Chhabra D; Parker MA; Leventhal JR; Kaufman DB Transplantation; 2007 May; 83(10):1324-9. PubMed ID: 17519781 [TBL] [Abstract][Full Text] [Related]
10. Calcineurin inhibitors in renal transplantation: what is the best option? Tanabe K Drugs; 2003; 63(15):1535-48. PubMed ID: 12887261 [TBL] [Abstract][Full Text] [Related]
11. Early post-transplant conversion from tacrolimus to belatacept for prolonged delayed graft function improves renal function in kidney transplant recipients. Wojciechowski D; Chandran S; Vincenti F Clin Transplant; 2017 May; 31(5):. PubMed ID: 28190259 [TBL] [Abstract][Full Text] [Related]
12. Improving long-term renal transplant outcomes with tacrolimus: speculation vs evidence. First MR Nephrol Dial Transplant; 2004 Dec; 19 Suppl 6():vi17-vi22. PubMed ID: 15575022 [TBL] [Abstract][Full Text] [Related]
13. Is acute rejection the key predictor for long-term outcomes after renal transplantation when comparing calcineurin inhibitors? Nashan B Transplant Rev (Orlando); 2009 Jan; 23(1):47-52. PubMed ID: 19027616 [TBL] [Abstract][Full Text] [Related]
15. Improved efficacy of basiliximab over antilymphocyte globulin induction therapy in paediatric renal transplantation. Clark G; Walsh G; Deshpande P; Koffman G Nephrol Dial Transplant; 2002 Jul; 17(7):1304-9. PubMed ID: 12105256 [TBL] [Abstract][Full Text] [Related]
16. ADHERE: randomized controlled trial comparing renal function in de novo kidney transplant recipients receiving prolonged-release tacrolimus plus mycophenolate mofetil or sirolimus. Rummo OO; Carmellini M; Rostaing L; Oberbauer R; Christiaans MH; Mousson C; Langer RM; Citterio F; Charpentier B; Brown M; Kazeem G; Lehner F; Transpl Int; 2017 Jan; 30(1):83-95. PubMed ID: 27754567 [TBL] [Abstract][Full Text] [Related]
17. Alemtuzumab induction with tacrolimus monotherapy in 25 pediatric renal transplant recipients. Sung J; Barry JM; Jenkins R; Rozansky D; Iragorri S; Conlin M; Al-Uzri A Pediatr Transplant; 2013 Dec; 17(8):718-25. PubMed ID: 24164824 [TBL] [Abstract][Full Text] [Related]
18. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes. Anil Kumar MS; Irfan Saeed M; Ranganna K; Malat G; Sustento-Reodica N; Kumar AM; Meyers WC Transpl Immunol; 2008 Nov; 20(1-2):32-42. PubMed ID: 18773960 [TBL] [Abstract][Full Text] [Related]
19. A randomized trial comparing renal function in older kidney transplant patients following delayed versus immediate tacrolimus administration. Andrés A; Budde K; Clavien PA; Becker T; Kessler M; Pisarski P; Fornara P; Burmeister D; Hené RJ; Cassuto-Viguier E; Transplantation; 2009 Nov; 88(9):1101-8. PubMed ID: 19898206 [TBL] [Abstract][Full Text] [Related]
20. Ten years of treatment with tacrolimus is related to an excellent renal function, allowing monotherapy in a large proportion of cases: unicentric results of the tacrolimus versus cyclosporine A European Multicentric Study in kidney transplant patients. Morales JM; Andrés A; Dominguez-Gil B; Arriola M; Gutiérrez MJ; Hernández E; Ortuño T; Praga M Transplant Proc; 2005 Nov; 37(9):3738-42. PubMed ID: 16386523 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]